Pay in 4 interest-free payments of $5.88 Learn more
Ships within 48 hours · Estimated delivery Sep 22 - Sep 27
This is why slow dose increases and good communication with a healthcare provider can help
R13.13: Pharyngeal phase
Endocrinology 159 (4), 15701584
The symptoms often follow a pattern where: Many patients report improvement in nausea and malaise after the first few weeks Symptoms often become more manageable or resolve completely with continued treatment Some patients may experience mild symptoms that persist longer, though these typically become less bothersome over time Factors affecting duration: Several variables influence how long symptoms persist: Dose escalation schedule slower titration (gradual dose increases) typically results in fewer and shorter-lasting symptoms Individual sensitivity some patients are more susceptible to gastrointestinal side effects Concurrent medications other drugs affecting the GI tract may prolong symptoms Dietary habits eating patterns and food choices can influence symptom severity and duration It is worth noting that symptoms may temporarily recur when the dose is increased according to the recommended schedule (which varies by product weekly for liraglutide, every 4 weeks for weekly semaglutide), but subsequent episodes are often less severe than the initial experience
It also separates medical facts from online claims that may not apply to an individual patient
